[1]
|
G. Oxenkrug, “Metabolic Syndrome, Age-Associated Neuroendocrine Disorders and Dysregulation of TryptophanKynurenine Pathway Metabolism,” Annals of the New York Academy of Sciences, Vol. 1199, 2010, pp. 1-14.
|
[2]
|
G. Oxenkrug, “Interferon-Gamma-Inducible Kynurenines/ Pteridines Inflammation Cascade: Implications for Aging and Aging-Associated Medical and Psychiatric Disorders,” Journal of Neural Transmission, Vol. 118, No. 1, 2011, pp. 75-85. http://dx.doi.org/10.1007/s00702-010-0475-7
|
[3]
|
G. Oxenkrug, “Interferon-Gamma—Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders,” Aging and Disease, Vol. 2, No. 6, 2011, pp. 474-486.
|
[4]
|
G. Oxenkrug, “The Extended Life Span of Drosophila melanogaster Eye-Color (White and Vermilion) Mutants with Impaired Formation of Kynurenine,” Journal of Neural Transmission, Vol. 117, No. 1, 2010, pp. 23-26. http://dx.doi.org/10.1007/s00702-009-0341-7
|
[5]
|
G. Oxenkrug, V. Navrotskaya, L. Vorobyova and P. Summergrad, “Extension of Life Span of Drosophila melanogaster by the Inhibitors of Tryptophan-Kynurenine Metabolism,” Fly (Austin), Vol. 5, No. 4, 2011, pp. 307-309. http://dx.doi.org/10.4161/fly.5.4.18414
|
[6]
|
S. Campesan, E. W. Green, C. Breda, K. V. Sathyasaikumar, P. J. Muchowski, R. Schwarcz and C. P. Kyriacou, “The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington’s Disease,” Current Biology, Vol. 21, No. 11, pp. 961-966. http://dx.doi.org/10.1016/j.cub.2011.04.028
|
[7]
|
V. V. Navrotskaya, G. Oxenkrug, L. I. Vorobyova and P. Summergrad, “Berberine Prolongs Life Span and Stimulates Locomotor Activity of Drosophila melanogaster,” American Journal of Plant Sciences, Vol. 3, No. 7, 2012, pp. 1037-1040. http://dx.doi.org/10.4236/ajps.2012.327123
|
[8]
|
G. Oxenkrug, V. Navrotskaya, L. Vorobyova and P. Summergrad, “Minocycline Effect on Life and Health Span of Drosophila melanogaster,” Aging and Disease, Vol. 3, No. 5, 2012, pp. 352-359.
|
[9]
|
E. Bonilla, R. Contreras, E. J. Medina-Leendertz, M. Mora, V. Villalobos and Y. Bravo, “Minocycline Increases the Life Span and Motor Activity and Decreases Lipid Peroxidation in Manganese Treated Drosophila Melanogaster,” Toxicology, Vol. 294, No. 1, 2012, pp. 50-53. http://dx.doi.org/10.1016/j.tox.2012.01.016
|
[10]
|
M. Mora, S. J. Medina-Leendertz, E. Bonilla, R. E. Terán, M. C. Paz and J. L. Arcaya, “Minocycline, but Not Ascorbic Acid, Increases Motor Activity and Extends the Life Span of Drosophila melanogaster,” Investigación Clínica, Vol. 54, No. 2, 2013, pp. 161-170.
|
[11]
|
J. Miquel, P. R. Lundgren, K. G. Bensch and H. Atlan, “Effects of Temperature on the Life Span, Vitality and Fine Structure of Drosophila melanogaster,” Mechanisms of Ageing and Development, Vol. 5, 1976, pp. 347-370. http://dx.doi.org/10.1016/0047-6374(76)90034-8
|
[12]
|
E. A. Sestini, J. C. Carlson and R. Allsopp, “The Effects of Ambient Temperature on Life Span, Lipid Peroxidation, Superoxide Dismutase, and Phospholipase A2 Activity in Drosophila melanogaster,” Experimental Gerontology, Vol. 26, No. 4, 1991, pp. 385-395. http://dx.doi.org/10.1016/0531-5565(91)90050-V
|
[13]
|
C. J. Yu, M. F. Zheng, C. X. Kuang, W. D. Huang and Q. Yang, “Oren-Gedoku-To and Its Constituents with Therapeutic Potential in Alzheimer’s Disease Inhibit Indoleamine 2,3-Dioxygenase Activity in Vitro,” Journal of Alzheimer’s Disease, Vol. 22, No. 1, 2010, pp. 257-266.
|
[14]
|
M. G. Kamyshev, “Longevity and Its Relation to the Locomotor Activity in Tryptophan-Xanthommatin Metabolic Pathway Mutant of Drosophila,” Doklady Akademii Nauk SSSR, Vol. 253, No. 5, 1980, pp. 1476-1480.
|
[15]
|
D. Fusco, G. Colloca, M. R. Lo Monaco and M. Cesari, “Effects of Antioxidant Supplementation on the Aging Process,” Journal of Clinical Interventions in Aging, Vol. 2, No. 3, 2007, pp. 377-387.
|
[16]
|
H. F. Ji and L. Shen, “Berberine, a Potential Multipotent Natural Product to Combat Alzheimer’s Disease,” Molecules, Vol. 16, No. 8, 2011, pp. 6732-6740. http://dx.doi.org/10.3390/molecules16086732
|